Dr. Mansoor A. Khan serves as a professor and Vice Dean of the Texas A&M University Rangel College of Pharmacy at College Station, Texas. Prior to joining Texas A&M in 2015, he served as the Director of Product Quality Research and a Senior Biomedical Research Scientist (SBRS) at CDER in US Food and Drug Administration for over eleven years. In FDA, he led the research and review teams to promote manufacturing science, and served as a founding member of the FDA Emerging Technology Team. Dr. Khan received his Ph.D. degree in industrial pharmacy form St. Johns University in NY. He has published over 335 peer-reviewed manuscripts in pharmaceutical formulations and manufacturing sciences, and delivered over 300 presentations world-wide. Dr. Khan's research, currently supported by the NIH and FDA, spans drug delivery and formulations, and he has received over ten million dollars in funding as a principal investigator.
Dr. Khan has held leadership positions at the AAPS including elected chair of formulations design and development (FDD) section. He serves on the editorial board of Pharmaceutical Technology, International Journal of Pharmaceutics, AAPSPharmsciTech, and the Drug Delivery and Translational Research. He has received about 20 FDA/CDER review, research, and exemplary achievement awards, outstanding alumni award at St. Johns University College of Pharmacy, Excellence Award in Texas A&M University. He received the 2012 AAPS Research Achievement Award in Formulations Design and Development. He is also an AAPS and AAiPS Fellow. Dr. Khan served as FDA representative to the World Health Organization (WHO), United States Pharmacopoeia (USP), European Medicine Agency (EMA), DARPA, NIH, National Institute of Pharmaceutical Technology and Education (NIPTE), and International Pharmaceutical Federation (FIP). He is also a member of the European Union Academy of Sciences.